Ryan Fleming

Ryan Fleming practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Ryan Fleming's NPI, 1417341892, was assigned on March 24, 2015. Ryan Fleming graduated from University of Texas Southwestern Medical School at Dallas in 2015. Ryan Fleming holds Texas license S4949.

Ryan Fleming's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Ryan Fleming's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Ryan Fleming is also affiliated with Texas Health Hospital Frisco. The medical group on file is University of Texas Southwestern Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Ryan Fleming practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ryan Fleming's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ryan Fleming is licensed in Texas.

CMS data shows 543 Medicare services from Ryan Fleming across 6 procedure codes in 2024, for 202 Medicare patients. Medicare paid $43,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Ryan Fleming in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ryan Fleming's median patient age at 63, with 55% women.

In 2024, Ryan Fleming wrote 389 Medicare Part D claims for 138 patients. 85% of them were for generic drugs. CMS names the drug for 122 of them, across 8 drugs with 11 or more claims each, at $16,759 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Ryan Fleming for performance year 2024, reported as part of a group. Ryan Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Ryan Fleming, published from 2014 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Antibodies, Monoclonal, Immunoconjugates and Antineoplastic Agents. Ryan Fleming has published most often in MAbs. Ryan Fleming's most frequent co-authors are Ulrike Gerdemann, MD, Bruce Robert Blazar, MD and Kenneth C. Anderson, MD.

CMS Open Payments shows 1 general payment to Ryan Fleming from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Zimmer Biomet Holdings, Inc. paid the most, $105.

Ryan Fleming graduated from University of Texas Southwestern Medical School at Dallas in 2015.